Europe — EMA

Ozep (Eslicarbazepine Acetate)

Eslicarbazepine acetate, the active ingredient in Ozep, is a anticonvulsant presented as a oral tablet for oral use. It is used to treat partial-onset seizures in adults.

Eslicarbazepine Acetate

Request sourcing

Pack/s

What is Eslicarbazepine Acetate?

Eslicarbazepine acetate, the active ingredient in Ozep, is a anticonvulsant presented as a oral tablet for oral use. It is used to treat partial-onset seizures in adults. GNH USA supplies Ozep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ozep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Eslicarbazepine Acetate used for?

Eslicarbazepine acetate is indicated for the management of seizure disorders within the broader class of epilepsy therapies.

- Partial onset seizures: Reduces seizure frequency and severity. - Adjunctive therapy in epilepsy: Enhances overall seizure control when added to other antiepileptic drugs. - Focal onset seizures: Provides additional seizure protection. - Monotherapy : Offers A treatment option for patients who prefer single‑drug therapy. -

What are the side effects of Eslicarbazepine Acetate?

The

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →